Amgen Latest Drug Maker to Respond to Trump’s Call to Reduce US Prices

Amgen Latest Drug Maker to Respond to Trump’s Call to Reduce US Prices

An Amgen company office in South San Francisco on Oct. 21, 2013. Robert Galbraith/Reuters

Amgen announced that it will offer discounted, direct-to-consumer sales of Repatha, an injectable drug used to treat high cholesterol, through a new consumer portal. 

In an Oct. 6 statement, the company said the move was “in support of the Trump Administration’s efforts to lower drug prices for Americans.”

We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.

Original News Source Link – Epoch Times

Running For Office? Conservative Campaign Consulting – Election Day Strategies!